Navigation Links
AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results
Date:11/6/2012

st today, November 6, at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss its financial results and program updates. To listen to the conference call, dial in approximately ten minutes before the scheduled call to (800) 860-2442 for domestic callers, (866) 605-3852 for Canadian callers, or (412) 858-4600 for international callers. Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of the company's website at www.acelrx.com. A webcast replay will be available on the AcelRx website for 90 days following the call by visiting the Investor Relations section of the company's website at www.acelrx.com.

About AcelRx Pharmaceuticals, Inc.
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. AcelRx's lead product candidate, the ARX-01 Sufentanil NanoTab PCA System, is currently in Phase 3 clinical development and is designed to solve problems associated with post-operative intravenous patient-controlled analgesia, including side effects of morphine, invasive IV route of delivery and the inherent potential for programming and delivery errors associated with the complexity of infusion pumps.  AcelRx has two additional product candidates that have completed Phase 2 clinical development: ARX-02 for the treatment of cancer breakthrough pain and ARX-03 for mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician's office.  AcelRx has initiated a Phase 2 study for a fourth product candidate, ARX-04, a sufentanil formulation for the treatment of moderate-to-severe acute pain, funded through a grant from the USAMRMC.
For additional information about AcelRx's clinical programs please visit

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical Study
2. AcelRx Pharmaceuticals to Hold Third Quarter 2012 Financial Results Conference Call and Webcast on November 6, 2012
3. AcelRx Pharmaceuticals Hires Mike A. Royal, M.D. as Chief, Clinical Affairs
4. AcelRx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
5. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
6. AcelRx Pharmaceuticals to Present at Three Upcoming Investor Conferences
7. AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
8. AcelRx Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Healthcare Conference
9. AcelRx Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call and Webcast on August 9, 2012
10. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
11. AcelRx Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... and LONDON , August 28, 2015 /PRNewswire/ ... approach seamlessly connects people, technologies and ... improving outcomes and the cost of healthcare ... AEX: PHIA) today announced its presence at  ESC Congress 2015 ... including Heart Model A.I. , EchoNavigator and IntelliSpace Cardiovascular, that ...
(Date:8/27/2015)... 2015  A recent study by Feucht et ... the Arthrosurface HemiCAP® Wave implant, which is based ... design implant for isolated patellofemoral disease. While both ... pain scores, none of the patients in the ... 53% of the patients in the "onlay" group, ...
(Date:8/27/2015)... RIVERSIDE, Calif. , Aug. 27, 2015 /PRNewswire/ ... important milestone in the commercial development of the ... . The Smart Oxygen device, being developed by ... adjusts to a patient,s changing demand for oxygen ... that the 510 (k) submission for the Smart ...
Breaking Medicine Technology:Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 4Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4
... 8, 2011 Reportlinker.com announces that a new ... Europe Drug Delivery Devices Market ... Europe Drug Delivery Devices Market ... GlobalData,s new report, "Europe Drug Delivery ...
... June 8, 2011 Edison Pharmaceuticals, Inc. announced ... has granted orphan drug designation to EPI-743 for ... these mitochondrial diseases affect an estimated 60,000 individuals. ... 1982, provides incentives for companies to pursue treatments ...
Cached Medicine Technology:Reportlinker Adds Europe Drug Delivery Devices Market Outlook to 2017 2Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation 2
(Date:8/28/2015)... ... 2015 , ... With the goal of furthering music education programs in schools, ... Adams County Fairgrounds in Mendon, IL on May 30th, 2015. Backed once again by ... in the underfunded school districts of Mendon and its neighboring town of Quincy, IL. ...
(Date:8/28/2015)... ... 28, 2015 , ... The 6th Annual Survivor in the City, Chicago ... yet another accolade to its cadre of widespread support—an official letter of support and ... of the medical community and the University of Illinois at Chicago’s Department of Neurosurgery, ...
(Date:8/28/2015)... , ... August 28, 2015 , ... “ Frequentz ” ... at the latest and coolest applications on the market for iOS, Android, and Windows. ... shared with viewers how this software allows businesses to track product movement from beginning ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... of the Veterans Award, honoring military veterans leading in business. Mr. Troy ... , The inaugural Nashville Business Journal's 2015 Veterans Awards will recognize ...
(Date:8/28/2015)... ... , ... The Quatela Center for Plastic Surgery is excited to bring patients ... approved by the Food and Drug Administration to eliminate submental fat, also known as ... are among the premier cosmetic surgeons in Rochester to offer this innovative procedure.     ...
Breaking Medicine News(10 mins):Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3
... Calif., March 20 IPC The,Hospitalist Company, Inc. ... hospitalist,services, announced today the election of Woodrin Grossman ... on the audit and nominating and,governance committees., ... and healthcare practice,leader of PricewaterhouseCoopers after 37 years ...
... Affiliated Computer,Services, Inc. (NYSE: ACS ) announced ... provide business process outsourcing (BPO), information,technology outsourcing (ITO), ... Affordable Quality Healthcare. The multi-million dollar deal,has a ... options, including a,six-month implementation period., CAQH is ...
... G. Ryan, founder,and executive chairman of Aon Corporation, today ... 2008. Aon is the world,s largest,insurance and reinsurance intermediary, ... commented, "The transition to a new management team under ... extremely well-positioned,for continued growth and success. After 41 years ...
... yourself!" , Most of us haven,t heard that admonition ... often tell ourselves, consciously or not, as we deal ... regulate one,s emotions is critical to successfully interacting with ... an equally important effect on our own well-being. , ...
... Hughes Lists 2007 Accomplishments and Reiterates Plans for Growth, ... SMBL ) announced today that members of its ... Las Vegas, NV, at 12:25 p.m.,EDT on Wednesday, March ... present at the conference, Smart,Balance Chairman and CEO Stephen ...
... Osteoporosis drug also linked to bone pain and irregular heartbeats ... In the latest research to cast a shadow on ... long-term use of Fosamax is associated with unusual fractures of ... meaning that they all occurred from a fall from standing ...
Cached Medicine News:Health News:IPC The Hospitalist Company Announces Board of Director Member Changes 2Health News:ACS Awarded Contract to Provide Comprehensive Outsourcing Services for CAQH 2Health News:ACS Awarded Contract to Provide Comprehensive Outsourcing Services for CAQH 3Health News:ACS Awarded Contract to Provide Comprehensive Outsourcing Services for CAQH 4Health News:Patrick G. Ryan Announces Intention to Retire from Aon 2Health News:Patrick G. Ryan Announces Intention to Retire from Aon 3Health News:Disgusting videos used to study coping methods 2Health News:Disgusting videos used to study coping methods 3Health News:Disgusting videos used to study coping methods 4Health News:Smart Balance Presented at Citi Small/Midcap Conference 2Health News:Fosamax Linked to Unusual Femur Fractures 2Health News:Fosamax Linked to Unusual Femur Fractures 3
... DxSelect is intended for qualitatively detecting antibodies ... serum. The test is indicated for testing ... an aid in the presumptive laboratory diagnosis ... intended for self-testing, and this test is ...
... immunofluorescent antibody (IFA) test ... semi-quantitation of human serum ... viral capsid antigen (VCA). ... 12-well slides, FITC IgG ...
... portable, battery-powered, micro-controlled, noninvasive bone growth stimulator ... primary lumbar spinal fusion surgery for one ... been shown in pre-clinical studies to help ... Clinical studies have also shown that individuals ...
... Siemens Medical Solutions introduces its new ... system with intuitive patient data management ... lithotripter and urological table. Lithoskop is ... urodiagnostics that covers all applications like ...
Medicine Products: